Coronary disease & ACS

Complete revascularization in patients with acute myocardial infarction and multivessel disease: Pooled analysis of Kaplan-Meier-derived individual-patient-data

Am Heart JPublished Systematic review and meta-analysis of randomised trials

Pooled result · MACEResult — go to the resultHazard ratio 0.59 95% CI 0.54–0.66

Authors' conclusion

Complete revascularization results in lower risks of all-cause and cardiovascular mortality, MI, unplanned repeat revascularizations and MACE in patients with acute MI and multivessel disease.

Study context

Population
Patients with acute MI and multivessel disease without cardiogenic shock
Participants
9,658 patients9 RCTs
Comparison
Complete vs incomplete revascularization
  • Complete revascularizationn = 4,671
Outcome
Major adverse cardiac events (MACE)
Follow-up
5 years
Methodological detailsreconstructed individual-patient-data from published Kaplan-Meier curves
  • Reconstructed individual-patient-data from published Kaplan-Meier curves

Pooled result

As reported in the abstract

Hazard ratio

0.59

95% CI 0.54–0.66

P < 0.001

Complete revascularizationvs Incomplete revascularization
HR 0.59 (95% CI 0.54–0.66); P < 0.001

Further pooled results

OutcomeHR (95% CI)P value
All-cause mortality · 5 years0.64 (0.56–0.72)P < 0.001
CV mortality · 5 years0.82 (0.71–0.95)P = 0.008
MI · 5 years0.69 (0.55–0.87)P < 0.001
Unplanned repeat revascularizations · 5 years0.62 (0.54–0.71)P < 0.001

Original publication

Complete revascularization in patients with acute myocardial infarction and multivessel disease: Pooled analysis of Kaplan-Meier-derived individual-patient-data. Am Heart J. Published 2 October 2025. doi:10.1016/j.ahj.2025.107284

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.